Hsp70 - a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck

Validation of Heat Shock Protein 70 as a Tumor-Specific Biomarker for Monitoring the Outcome of Radiation Therapy in Tumor Mouse Models

(2014) Christine Bayer et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer

(2013) Lijuan Lin et al.   BMC CANCER

Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: A multi-institutional case–control study

(2012) Matthias Zimmermann et al.   CLINICA CHIMICA ACTA

Proteomics in colorectal cancer translational research: Biomarker discovery for clinical applications

(2012) Meike de Wit et al.   CLINICAL BIOCHEMISTRY

Serum HSP70

(2011) Sudhir K. Dutta et al.   PANCREAS

An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors

(2010) Naveen Dakappagari et al.   BIOMARKERS

Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer

(2010) Mark D. Hurwitz et al.   RADIOTHERAPY AND ONCOLOGY

Serum level of soluble 70-kD heat shock protein is associated with high mortality in patients with colorectal cancer without distant metastasis

(2009) Judit Kocsis et al.   CELL STRESS & CHAPERONES

Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma

(2008) Yoshihisa Fujita et al.   CANCER LETTERS

Circulating microRNAs as stable blood-based markers for cancer detection

(2008) P. S. Mitchell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA